GlassScriptPhysician profile
Anne M Dow
NPI 1356481253
$15,251.24
in general payments reported to CMS, 2019-2025
58 companies · $4,918 in 2025
The $4,918 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $871 · 2022: $1,835 · 2023: $3,693 · 2024: $3,934 · 2025: $4,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,627 · Travel and Lodging: $2,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,627.34 |
| Travel and Lodging | $2,917.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,683.77 | 2021-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $2,258.28 | 2021-2025 | |
| Abbott Laboratories | $1,685.42 | 2023-2025 | Infinity, Proclaim |
| Ucb, INC. | $729.22 | 2022-2025 | Rystiggo, Briviact, Fintepla |
| Pfizer INC. | $528.28 | 2022-2025 | |
| Emd Serono, INC. | $484.55 | 2022-2025 | Mavenclad, Mavenclad |
| Biogen, INC. | $442.02 | 2021-2025 | Skyclarys, Tysabri, Vumerity |
| Amneal Pharmaceuticals LLC | $431.76 | 2022-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Sk Life Science, INC. | $398.55 | 2022-2025 | Xcopri |
| Lilly USA, LLC | $361.14 | 2022-2025 | Kisunla, Emgality, Amyvid |
| Novartis Pharmaceuticals Corporation | $310.41 | 2021-2025 | |
| Lundbeck LLC | $288.63 | 2023-2025 | Vyepti, Rexulti |
| Biohaven Pharmaceuticals, INC. | $278.39 | 2021 | |
| Genzyme Corporation | $257.58 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $237.25 | 2022-2025 | Ultomiris, Koselugo, Soliris |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $228.26 | 2023-2025 | Rexulti, Nuedexta |
| Kyowa Kirin, INC. | $220.12 | 2021-2024 | Nourianz |
| Tg Therapeutics, INC. | $211.12 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $203.29 | 2022 | |
| Argenx US, INC. | $200.97 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $195.80 | 2021-2025 | Ingrezza, Ongentys |
| Eisai INC. | $192.43 | 2022-2025 | |
| Genentech USA, INC. | $171.26 | 2022-2025 | Ocrevus, Ocrevus Zunovo |
| Averitas Pharma INC. | $169.39 | 2025 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $159.69 | 2022-2025 | Austedo Xr, Austedo, Austedo Xr |
| Acadia Pharmaceuticals INC | $139.50 | 2021-2025 | Nuplazid |
| Jazz Pharmaceuticals INC. | $138.15 | 2022-2025 | |
| Amgen INC. | $127.24 | 2021-2025 | Aimovig, Uplizna |
| Takeda Pharmaceuticals U.S.A., INC. | $121.99 | 2023-2025 | Hyqvia, Gammagard |
| Impel Pharmaceuticals LLC | $102.11 | 2025 | Trudhesa |
| Mdd US Operations, LLC | $95.41 | 2023-2024 | Gocovri, Gocovri |
| Mallinckrodt Hospital Products INC. | $83.10 | 2022-2025 | Acthar |
| Tanabe Pharma America, INC. | $73.45 | 2024-2025 | Radicava |
| Janssen Pharmaceuticals, INC | $70.01 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $68.75 | 2025 | Xeomin, Inbrija, Ampyra |
| Supernus Pharmaceuticals, INC. | $68.16 | 2025 | Qelbree |
| Vanda Pharmaceuticals INC. | $63.02 | 2025 | Ponvory |
| Axsome Therapeutics, INC. | $61.42 | 2023-2024 | Sunosi |
| Novo Nordisk INC | $55.38 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Mylan Specialty L.P. | $50.74 | 2023-2024 | Glatiramer Acetate |
| Celgene Corporation | $49.67 | 2022-2025 | Zeposia |
| Xeris Pharmaceuticals, INC. | $49.27 | 2023-2025 | Keveyis |
| Ani Pharmaceuticals, INC. | $48.97 | 2023-2025 | Purified Cortrophin Gel |
| Azurity Pharmaceuticals, INC. | $46.61 | 2023 | Horizant |
| Impel Pharmaceuticals INC. | $43.97 | 2023 | Trudhesa |
| Sumitomo Pharma America, INC. | $42.72 | 2024 | Aptiom |
| Acorda Therapeutics, INC | $40.54 | 2023 | Ampyra, Inbrija |
| Neurelis, INC. | $40.39 | 2025 | Valtoco |
| Catalyst Pharmaceuticals, INC. | $39.60 | 2024 | |
| Life Molecular Imaging LTD | $32.77 | 2025 | Neuraceq |
| Medtronic, INC. | $31.80 | 2023 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Avion Pharmaceuticals | $25.45 | 2022 | |
| Banner Life Sciences, LLC | $24.03 | 2022 | |
| Cycle Pharmaceuticals INC | $23.24 | 2025 | Tascenso Odt, Bafiertam |
| Scilex Pharmaceuticals INC. | $22.87 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $14.58 | 2024 | Lumryz |
| Collegium Pharmaceutical, INC. | $14.48 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Dow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.